Molecular mechanisms of SARS-CoV-2 entry: implications for biomedical strategies
Microbiology and Molecular Biology Reviews · 2025
DOI: 10.1128/mmbr.00260-24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbiology and Molecular Biology Reviews, 2025. Verfasst von Irene Santamaria-Castro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Microbiología, Universidad de Málaga, Málaga, Spain. Hauptthemen laut MEDLINE: SARS-CoV-2, Virus Internalization, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 577 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The mechanisms by which viruses enter host cells are crucial for their ability to infect and cause disease, serving as major targets for both host immune responses and therapeutic strategies. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry process is primarily driven by the binding of the viral spike (S) protein to the angiotensin-converting enzyme 2 (ACE2) receptor, in conjunction with the activity of endosomal cathepsin L and the serine protease transmembrane protease serine 2 (TMPRSS2). Nevertheless, recent scientific advances have expanded our understanding of SARS-CoV-2 entry mechanisms, uncovering alternative receptors and novel cofactors that may enhance viral tropism and adaptability. Given the critical role of the SARS-CoV-2 S protein in mediating host cell entry, it has become a primary target for prevention and therapeutic strategies. However, the continuous spread of SARS-CoV-2 has led to the emergence of S protein variants that may potentially confer a fitness advantage or modify key aspects of SARS-CoV-2 biology, such as transmissibility, infectivity, antigenicity, and/or pathogenicity, posing significant challenges to the efficacy of current interventions. In this review, we provide an updated and comprehensive overview of the latest advances in SARS-CoV-2 entry pathways and molecular mechanisms, exploring their implications for antiviral drug discovery, vaccine design, and the development of other biomedical strategies while addressing the challenges posed by the ongoing evolution of the virus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Microbiología, Universidad de Málaga, Málaga, Spain.
- Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Málaga, Spain.
- Unidad de Gestión Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Regional Universitario de Málaga, Málaga, Spain.
ORCID-Profile: Rocio Leiva-Rebollo, Jose M Jimenez-Guardeño, Ana Maria Ortega-Prieto
Zitieren
APA
Santamaria-Castro, I., Leiva-Rebollo, R., Marín-Wong, S., Jimenez-Guardeño, J. M., & Ortega-Prieto, A. M. (2025). Molecular mechanisms of SARS-CoV-2 entry: implications for biomedical strategies. Microbiology and Molecular Biology Reviews. https://doi.org/10.1128/mmbr.00260-24
Vancouver
Santamaria-Castro I, Leiva-Rebollo R, Marín-Wong S, Jimenez-Guardeño JM, Ortega-Prieto AM. Molecular mechanisms of SARS-CoV-2 entry: implications for biomedical strategies. Microbiology and Molecular Biology Reviews. 2025. doi:10.1128/mmbr.00260-24
BibTeX
@article{SantamariaCastro2025,
author = {Santamaria-Castro, Irene and Leiva-Rebollo, Rocio and Marín-Wong, Sonia and Jimenez-Guardeño, Jose M and Ortega-Prieto, Ana Maria},
title = {Molecular mechanisms of SARS-CoV-2 entry: implications for biomedical strategies},
journal = {Microbiology and Molecular Biology Reviews},
year = {2025},
doi = {10.1128/mmbr.00260-24}
}
EUVIMED